Professional
Added to YB: 2024-09-05
Pitch date: 2024-07-11
NTRA [bullish]
Natera, Inc.
+83.34%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Market Cap
$28.0B
Pitch Price
$111.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
-110.32
P/E
-119.45
EV/Sales
10.85
Sector
Biotechnology
Category
growth
Show full summary:
Columbia Acorn Fund Portfolio Holding: Natera, Inc.
NTRA trimmed position: Leading genomic diagnostics co, top in prenatal screening & early in cancer recurrence monitoring. Strong Q1 results. 2024 inflection point w/ multiple clinical data catalysts. Upside potential despite recent gains. Position trimmed for risk management.
Read full article (1 min)